Recombinant Human VEGF-D (C-6His)
- Cat. No.：EPT213
- Price：Negotiable
- Clicks：1400
Product Detail
Basic Information
| Size | 10ug |
|---|
| Expression Host | Human Cells |
|---|
| Tag | C-6His |
|---|
Physical Properties
| Molecular Weight | 13 KDa |
|---|
| Apparent Molecular Weight | 18 KDa, reducing conditions |
|---|
| Form | Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4. |
|---|
| Purity | Greater than 95% as determined by reducing SDS-PAGE. |
|---|
Activity & Endotoxin
| Endotoxin Level | Less than 0.1 ng/µg (1 EU/µg) as determined by LAL test. |
|---|
| Activity | Immobilized Human VEGFR2-Fc(Cat#CJ92) at 5μg/ml (100 μl/well)can bind Human VEGF-D-His(Cat#C498).The ED50 of Human VEGF-D-His(Cat#C498) is 0.214 ug/ml. |
|---|
Storage & Shipping
| Reconstitution | Always centrifuge tubes before opening.Do not mix by vortex or pipetting.
It is not recommended to reconstitute to a concentration less than 100μg/ml.
Dissolve the lyophilized protein in distilled water.
Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
|---|
| Storage | Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks.
Reconstituted protein solution can be stored at 4-7°C for 2-7 days.
Aliquots of reconstituted samples are stable at < -20°C for 3 months. |
|---|
| Shipping Condition | The product is shipped at ambient temperature.
Upon receipt, store it immediately at the temperature listed below. |
|---|
Detailed Description
| Background | Vascular endothelial growth factor D (VEGF-D) is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family. It is highly expressed in lung, heart, small intestine and fetal lung, and at lower levels in skeletal muscle, colon, and pancreas. VEGF-D is growth factor active in angiogenesis, lymphangiogenesis and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. It may function in the formation of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. It undergoes a complex proteolytic maturation, generating multiple processed forms that bind and activate VEGFR-2 and VEGFR-3 receptors. |
|---|
